MRS2500 [2-Iodo-N6-methyl-(N)-methanocarba-2′-deoxyadenosine-3′,5′-bisphosphate], a Potent, Selective, and Stable Antagonist of the Platelet P2Y1 Receptor with Strong Antithrombotic Activity in Mice
| Autor: | Kenneth A. Jacobson, Marco Cattaneo, Eun Joo Roh, Béatrice Hechler, Christelle Nonne, François Lanza, Christian Gachet, Jean-Pierre Cazenave |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Blood Platelets
Male P2Y receptor Settore MED/09 - Medicina Interna Platelet Aggregation Pharmacology Article Mice Receptors Purinergic P2Y1 Deoxyadenine Nucleotides P2Y12 In vivo Thromboembolism Antithrombotic Purinergic P2 Receptor Antagonists Animals Medicine Platelet Receptor Mice Knockout Receptors Purinergic P2 business.industry Disease Models Animal Molecular Medicine Platelet aggregation inhibitor business Platelet Aggregation Inhibitors Ex vivo |
| Zdroj: | Journal of Pharmacology and Experimental Therapeutics. 316:556-563 |
| ISSN: | 1521-0103 0022-3565 |
| Popis: | The platelet P2Y(1) ADP receptor is an attractive target for new antiplatelet drugs. However, because of the lack of strong and stable antagonists, only a few studies have suggested that pharmacological inhibition of the P2Y(1) receptor could efficiently inhibit experimental thrombosis in vivo. Our aim was to determine whether the newly described potent and selective P2Y(1) receptor antagonist MRS2500 [2-iodo-N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate] could inhibit platelet function ex vivo and experimental thrombosis in mice in vivo. MRS2500 was injected intravenously into mice, and its effect on ex vivo platelet aggregation and in several models of thrombosis in vivo was determined. MRS2500 displayed high potency and stable and selective P2Y(1) receptor inhibition ex vivo. Although MRS2500 injection resulted in only moderate prolongation of the bleeding time, it provided strong protection in systemic thromboembolism induced by infusion of a mixture of collagen and adrenaline. MRS2500 also potently inhibited localized arterial thrombosis in a model of laser-induced vessel wall injury with two degrees of severity. Moreover, combination of MRS2500 with clopidogrel, the irreversible inhibitor of the platelet P2Y(12) receptor for ADP, led to increased antithrombotic efficacy compared with each alone. These results add further evidence for a role of the P2Y(1) receptor in thrombosis and validate the concept that targeting the P2Y(1) receptor could be a relevant alternative or complement to current antiplatelet strategies. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|